Salem Investment Counselors Inc X Biotech Inc. Transaction History

Salem Investment Counselors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$2.31 - $4.69 $1,155 - $2,345	-500 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$4.04 - $5.13 $2,020 - $2,565	500 New	500 $2,000
Q1 2018 May 15, 2018	SELL	$3.92 - $5.35 $1,960 - $2,675	-500 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$3.9 - $4.66 $1,950 - $2,330	500	500 $2,000

4.86M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $101M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.